The Over-The-Counter Drug Market report has been added to Technavio's offering. The over-the-counter drug market is estimated to grow by USD 58.54 billion during 2022-2027, growing at a CAGR of 6.53%. The report includes information on the product launches, sustainability, and prospects of leading vendors including Abbott Laboratories, Achelios Therapeutics Inc., AstraZeneca Plc, Bayer AG, BioGaia AB, Boehringer Ingelheim International GmbH, Bukwang Pharmaceutical Co. Ltd., Chr Hansen Holding AS, Cipla Ltd., CVS Health Corp., Eli Lilly and Co., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Lupin Ltd., Mankind Pharma Ltd., Novartis AG, Pfizer Inc., Reckitt Benckiser Group Plc, Sanofi SA, and Zydus Lifesciences Ltd.
Also in this issue: South Florida Wellness Fest at Linda Alfieri Salon - Page 7 at: https://wellnessspareview.com/current.php